$NUS
NU SKIN ENTERPRISES, INC.

2020 Q2 Form 10-Q Financial Statement

#000114036120017594 Filed on August 06, 2020

View on sec.gov

Income Statement

Concept 2020 Q2 2019 Q2
Revenue $612.4M $623.5M
YoY Change -1.79% -11.46%
Cost Of Revenue $154.1M $154.0M
YoY Change 0.06% -8.61%
Gross Profit $458.3M $469.5M
YoY Change -2.39% -12.34%
Gross Profit Margin 74.84% 75.3%
Selling, General & Admin $400.2M $395.3M
YoY Change 1.24% -12.72%
% of Gross Profit 87.32% 84.2%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $18.26M $19.05M
YoY Change -4.14% -10.28%
% of Gross Profit 3.99% 4.06%
Operating Expenses $400.2M $395.3M
YoY Change 1.24% -12.72%
Operating Profit $58.07M $74.20M
YoY Change -21.74% -10.35%
Interest Expense
YoY Change
% of Operating Profit
Other Income/Expense, Net $1.581M -$3.326M
YoY Change -147.53% -70.21%
Pretax Income $59.66M $70.88M
YoY Change -15.83% -1.01%
Income Tax $17.80M $24.50M
% Of Pretax Income 29.84% 34.57%
Net Earnings $41.90M $46.30M
YoY Change -9.5% -9.22%
Net Earnings / Revenue 6.84% 7.43%
Basic Earnings Per Share
Diluted Earnings Per Share $807.3K $828.3K
COMMON SHARES
Basic Shares Outstanding 51.90M
Diluted Shares Outstanding

Balance Sheet

Concept 2020 Q2 2019 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments $386.3M $368.4M
YoY Change 4.86% -10.19%
Cash & Equivalents $375.5M $360.6M
Short-Term Investments $10.80M $7.700M
Other Short-Term Assets $73.20M $65.60M
YoY Change 11.59% -7.48%
Inventory $262.0M $292.7M
Prepaid Expenses
Receivables $64.40M $61.60M
Other Receivables $0.00 $0.00
Total Short-Term Assets $785.8M $788.2M
YoY Change -0.3% -3.29%
LONG-TERM ASSETS
Property, Plant & Equipment $587.5M $443.0M
YoY Change 32.62% -12.02%
Goodwill $196.6M $196.6M
YoY Change 0.0%
Intangibles $84.48M
YoY Change
Long-Term Investments
YoY Change
Other Assets $148.4M $160.4M
YoY Change -7.46% 10.9%
Total Long-Term Assets $1.009B $1.003B
YoY Change 0.58% 7.68%
TOTAL ASSETS
Total Short-Term Assets $785.8M $788.2M
Total Long-Term Assets $1.009B $1.003B
Total Assets $1.795B $1.791B
YoY Change 0.19% 2.56%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $51.70M $48.55M
YoY Change 6.49% -17.57%
Accrued Expenses $338.0M $306.5M
YoY Change 10.28% 5.44%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00
YoY Change
Long-Term Debt Due $95.00M $59.50M
YoY Change 59.66% -38.97%
Total Short-Term Liabilities $484.6M $414.5M
YoY Change 16.91% -7.29%
LONG-TERM LIABILITIES
Long-Term Debt $319.9M $349.0M
YoY Change -8.34% -5.8%
Other Long-Term Liabilities $197.9M $192.6M
YoY Change 2.75% 53.71%
Total Long-Term Liabilities $517.8M $541.6M
YoY Change -4.39% 9.24%
TOTAL LIABILITIES
Total Short-Term Liabilities $484.6M $414.5M
Total Long-Term Liabilities $517.8M $541.6M
Total Liabilities $1.003B $956.1M
YoY Change 4.85% 1.41%
SHAREHOLDERS EQUITY
Retained Earnings
YoY Change
Common Stock
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $792.0M $835.0M
YoY Change
Total Liabilities & Shareholders Equity $1.795B $1.791B
YoY Change 0.19% 2.56%

Cashflow Statement

Concept 2020 Q2 2019 Q2
OPERATING ACTIVITIES
Net Income $41.90M $46.30M
YoY Change -9.5% -9.22%
Depreciation, Depletion And Amortization $18.26M $19.05M
YoY Change -4.14% -10.28%
Cash From Operating Activities $97.10M $82.70M
YoY Change 17.41% 56.04%
INVESTING ACTIVITIES
Capital Expenditures $9.305M $15.45M
YoY Change -39.77% -2.08%
Acquisitions
YoY Change
Other Investing Activities $0.00 -$800.0K
YoY Change -100.0%
Cash From Investing Activities -$9.300M -$16.30M
YoY Change -42.94% 3.82%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -69.50M -13.70M
YoY Change 407.3% -64.87%
NET CHANGE
Cash From Operating Activities 97.10M 82.70M
Cash From Investing Activities -9.300M -16.30M
Cash From Financing Activities -69.50M -13.70M
Net Change In Cash 18.30M 52.70M
YoY Change -65.28% -3200.0%
FREE CASH FLOW
Cash From Operating Activities $97.10M $82.70M
Capital Expenditures $9.305M $15.45M
Free Cash Flow $87.80M $67.25M
YoY Change 30.55% 80.67%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2019Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
875289000
us-gaap Net Income Loss
NetIncomeLoss
61581000
dei Entity Central Index Key
EntityCentralIndexKey
0001021561
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
dei Amendment Flag
AmendmentFlag
false
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2020
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q2
us-gaap Gain Loss On Disposition Of Assets
GainLossOnDispositionOfAssets
0
us-gaap Repayments Of Long Term Debt
RepaymentsOfLongTermDebt
62500000
us-gaap Nature Of Operations
NatureOfOperations
<table cellpadding="0" cellspacing="0" class="DSPFListTable" id="z84a0f5a0fc4d474295b3d9805011c489" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;"> <tr> <td style="width: 36pt; vertical-align: top; align: right; font-family: 'Times New Roman'; font-size: 10pt;">1.</td> <td style="width: auto; vertical-align: top; text-align: left;"><div style="font-family: 'Times New Roman'; font-size: 10pt;"><span style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold;">The Company</span></div></td> </tr> </table> <div><br/></div> <div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt;"><span style="font-size: 10pt; font-family: 'Times New Roman'; color: #000000;">Nu Skin Enterprises, Inc. (the “Company”) is a holding company, with Nu Skin, a leading global direct selling company, being the primary operating unit.  Nu Skin develops and distributes premium-quality, innovative personal care products and wellness products that are sold worldwide under the Nu Skin, Pharmanex and ageLOC brands and a small number of other products and services.  The Company reports revenue from </span>nine<span style="font-size: 10pt; font-family: 'Times New Roman'; color: #000000;"> segments, consisting of its </span>seven<span style="font-size: 10pt; font-family: 'Times New Roman'; color: #000000;"> geographic Nu Skin segments</span><span style="font-size: 10pt; font-family: 'Times New Roman'; color: #000000;">—</span><span style="font-size: 10pt; font-family: 'Times New Roman'; color: #000000;">Mainland China; South Korea; Southeast Asia, which includes Indonesia, Malaysia, the Philippines, Singapore, Thailand and Vietnam; Americas/Pacific, which includes Australia, Canada, Latin America, New Zealand and the United States; Japan; Hong Kong/Taiwan, which also includes Macau; and Europe, Middle East and Africa (“EMEA”), which includes several markets in Europe as well as Israel, Russia and South Africa</span><span style="font-size: 10pt; font-family: 'Times New Roman'; color: #000000;">—its Manufacturing segment, which includes manufacturing and packaging subsidiaries; and its </span>Grow Tech segment, which focuses on developing controlled-environment agriculture technologies<span style="font-size: 10pt; font-family: 'Times New Roman'; color: #000000;"> (the Company’s subsidiaries operating within each segment are collectively referred to as the “Subsidiaries”).</span></div>
us-gaap Gain Loss On Disposition Of Assets
GainLossOnDispositionOfAssets
-2580000
CY2020Q2 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
792012000
CY2018Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
781867000
us-gaap Net Income Loss
NetIncomeLoss
89351000
us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
-1342000
us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
2376000
us-gaap Stock Issued During Period Value Share Based Compensation Gross
StockIssuedDuringPeriodValueShareBasedCompensationGross
8324000
us-gaap Dividends Common Stock Cash
DividendsCommonStockCash
40042000
us-gaap Treasury Stock Value Acquired Cost Method
TreasuryStockValueAcquiredCostMethod
825000
us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
-2308000
us-gaap Stock Issued During Period Value Share Based Compensation Gross
StockIssuedDuringPeriodValueShareBasedCompensationGross
8634000
us-gaap Dividends Common Stock Cash
DividendsCommonStockCash
41084000
CY2019Q2 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
834950000
nus Proceeds From Stock Options Exercised Net Of Taxes Paid
ProceedsFromStockOptionsExercisedNetOfTaxesPaid
2376000
nus Proceeds From Stock Options Exercised Net Of Taxes Paid
ProceedsFromStockOptionsExercisedNetOfTaxesPaid
-2308000
us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
-8149000
us-gaap Treasury Stock Value Acquired Cost Method
TreasuryStockValueAcquiredCostMethod
107367000
us-gaap Repayments Of Long Term Debt
RepaymentsOfLongTermDebt
152455000
us-gaap Number Of Reportable Segments
NumberOfReportableSegments
9
nus Number Of Geographic Reportable Segments
NumberOfGeographicReportableSegments
7
CY2020Q2 us-gaap Contract With Customer Liability Revenue Recognized
ContractWithCustomerLiabilityRevenueRecognized
-4100000
CY2019Q2 us-gaap Contract With Customer Liability Revenue Recognized
ContractWithCustomerLiabilityRevenueRecognized
600000
us-gaap Contract With Customer Liability Revenue Recognized
ContractWithCustomerLiabilityRevenueRecognized
-3500000
us-gaap Contract With Customer Liability Revenue Recognized
ContractWithCustomerLiabilityRevenueRecognized
1100000
CY2020Q2 us-gaap Goodwill
Goodwill
196573000
CY2019Q4 us-gaap Goodwill
Goodwill
196573000
CY2020Q2 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P6Y1M6D
CY2020Q2 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.047
CY2019Q2 us-gaap Lease Cost
LeaseCost
11999000
CY2020Q2 us-gaap Operating Lease Cost
OperatingLeaseCost
12869000
CY2019Q2 us-gaap Operating Lease Cost
OperatingLeaseCost
12417000
us-gaap Operating Lease Cost
OperatingLeaseCost
26005000
us-gaap Operating Lease Cost
OperatingLeaseCost
25278000
CY2020Q2 us-gaap Variable Lease Cost
VariableLeaseCost
410000
CY2019Q2 us-gaap Variable Lease Cost
VariableLeaseCost
1105000
us-gaap Variable Lease Cost
VariableLeaseCost
1384000
us-gaap Variable Lease Cost
VariableLeaseCost
2157000
CY2020Q2 us-gaap Short Term Lease Cost
ShortTermLeaseCost
95000
CY2019Q2 us-gaap Short Term Lease Cost
ShortTermLeaseCost
52000
us-gaap Short Term Lease Cost
ShortTermLeaseCost
140000
us-gaap Short Term Lease Cost
ShortTermLeaseCost
104000
CY2020Q2 us-gaap Sublease Income
SubleaseIncome
1058000
CY2019Q2 us-gaap Sublease Income
SubleaseIncome
1575000
us-gaap Sublease Income
SubleaseIncome
2189000
us-gaap Sublease Income
SubleaseIncome
3168000
CY2020Q2 us-gaap Lease Cost
LeaseCost
12316000
us-gaap Lease Cost
LeaseCost
25340000
us-gaap Lease Cost
LeaseCost
24371000
us-gaap Operating Lease Payments
OperatingLeasePayments
25955000
us-gaap Operating Lease Payments
OperatingLeasePayments
26570000
us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
31178000
us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
140585000
CY2020Q2 us-gaap Lessee Operating Lease Liability Payments Remainder Of Fiscal Year
LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear
27085000
CY2020Q2 us-gaap Lessee Operating Lease Liability Payments Due Next Twelve Months
LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
46780000
CY2020Q2 us-gaap Lessee Operating Lease Liability Payments Due Year Two
LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
30950000
CY2020Q2 us-gaap Lessee Operating Lease Liability Payments Due Year Three
LesseeOperatingLeaseLiabilityPaymentsDueYearThree
21409000
CY2020Q2 us-gaap Lessee Operating Lease Liability Payments Due Year Four
LesseeOperatingLeaseLiabilityPaymentsDueYearFour
16604000
CY2020Q2 nus Lessee Operating Lease Liability To Be Paid After Year Four
LesseeOperatingLeaseLiabilityToBePaidAfterYearFour
27835000
CY2020Q2 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
170663000
CY2020Q2 us-gaap Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
26054000
CY2020Q2 us-gaap Operating Lease Liability
OperatingLeaseLiability
144609000
CY2020Q2 nus Lessee Operating Lease Lease Not Yet Commenced Liability Not Accrued
LesseeOperatingLeaseLeaseNotYetCommencedLiabilityNotAccrued
28200000
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
28692000
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
29214000
CY2020Q2 us-gaap Stock Repurchase Program Remaining Authorized Repurchase Amount1
StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1
362800000
CY2020Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
17800000
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
28500000
CY2019Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
24500000
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
47300000
CY2020Q2 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.298
us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.316
CY2019Q2 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.346
us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.346
CY2020Q2 us-gaap Deferred Tax Assets Liabilities Net
DeferredTaxAssetsLiabilitiesNet
20300000
CY2019Q4 us-gaap Deferred Tax Assets Liabilities Net
DeferredTaxAssetsLiabilitiesNet
20000000.0
CY2019Q4 us-gaap Undistributed Earnings Of Foreign Subsidiaries
UndistributedEarningsOfForeignSubsidiaries
60000000.0
CY2019Q4 us-gaap Deferred Tax Liability Not Recognized Amount Of Unrecognized Deferred Tax Liability Undistributed Earnings Of Foreign Subsidiaries
DeferredTaxLiabilityNotRecognizedAmountOfUnrecognizedDeferredTaxLiabilityUndistributedEarningsOfForeignSubsidiaries
6000000.0
us-gaap Number Of Reportable Segments
NumberOfReportableSegments
9
nus Number Of Geographic Reportable Segments
NumberOfGeographicReportableSegments
7
CY2020Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
612366000
CY2019Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
623500000
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
1130394000
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
1247123000
CY2020Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
58074000
CY2019Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
74202000
us-gaap Operating Income Loss
OperatingIncomeLoss
94639000
us-gaap Operating Income Loss
OperatingIncomeLoss
142855000
CY2020Q2 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
1581000
CY2019Q2 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-3326000
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-4593000
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-6174000
CY2020Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
59655000
CY2019Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
70876000
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
90046000
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
136681000
CY2020Q2 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
18264000
CY2019Q2 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
19052000
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
37359000
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
38659000
CY2020Q2 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
9305000
CY2019Q2 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
15449000
CY2019 us-gaap Impairment Of Long Lived Assets Held For Use
ImpairmentOfLongLivedAssetsHeldForUse
48600000
CY2019 us-gaap Restructuring Charges
RestructuringCharges
22100000
CY2019 us-gaap Severance Costs1
SeveranceCosts1
20100000
CY2019 us-gaap Other Restructuring Costs
OtherRestructuringCosts
2000000.0
CY2018Q4 us-gaap Restructuring Reserve
RestructuringReserve
15462000
CY2019Q1 us-gaap Payments For Restructuring
PaymentsForRestructuring
15046000
CY2019Q1 us-gaap Restructuring Reserve Translation And Other Adjustment
RestructuringReserveTranslationAndOtherAdjustment
-416000
CY2019Q1 us-gaap Restructuring Reserve
RestructuringReserve
0
CY2019Q2 us-gaap Restructuring Reserve Period Increase Decrease
RestructuringReservePeriodIncreaseDecrease
0
us-gaap Restructuring Reserve Period Increase Decrease
RestructuringReservePeriodIncreaseDecrease
0
CY2020Q2 us-gaap Restructuring Reserve Period Increase Decrease
RestructuringReservePeriodIncreaseDecrease
0

Files In Submission

Name View Source Status
0001140361-20-017594-index-headers.html Edgar Link pending
0001140361-20-017594-index.html Edgar Link pending
0001140361-20-017594.txt Edgar Link pending
0001140361-20-017594-xbrl.zip Edgar Link pending
brhc10013995_10q.htm Edgar Link pending
brhc10013995_10q_htm.xml Edgar Link completed
brhc10013995_ex31-1.htm Edgar Link pending
brhc10013995_ex31-2.htm Edgar Link pending
brhc10013995_ex32-1.htm Edgar Link pending
brhc10013995_ex32-2.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
nus-20200630.xsd Edgar Link pending
nus-20200630_cal.xml Edgar Link unprocessable
nus-20200630_def.xml Edgar Link unprocessable
nus-20200630_lab.xml Edgar Link unprocessable
nus-20200630_pre.xml Edgar Link unprocessable
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending